Cirrus Therapeutics Partners SERI, Duke-NUS For Eye Disease Therapies
KUALA LUMPUR, Aug 5 (Bernama) -- Cirrus Therapeutics has announced a collaboration with Singapore Eye Research Institute (SERI) and Duke-NUS Medical School (Duke-NUS) to advance innovative ophthalmic technologies for the treatment of blinding diseases.